Dr. Michelle Rozen's national study of more than 5,000 professionals reveals that AI initiatives don't fail because teams can't learn the technology. They fail because of four behavioral barriers most leaders never measure.
This Scorecard has been designed to show senior leaders where AI adoption is breaking down inside their organization.
- Based on a published study of 5,000+ professionals
- Used by Fortune 500 leadership teams
- Built on the AI Readiness Behavioral Model™
Dr. Michelle Rozen's national study of more than 5,000 professionals reveals that AI initiatives don't fail because teams can't learn the technology. They fail because of four behavioral barriers most leaders never measure.
This Scorecard has been designed to show senior leaders where AI adoption is breaking down inside their organization.
- Based on a published study of 5,000+ professionals
- Used by Fortune 500 leadership teams
- Built on the AI Readiness Behavioral Model™
Most leaders know AI adoption is
leaking. Few can name where.
In 20 yes-or-no questions, the assessment will diagnose your organization across
the
four behaviors that determine whether AI investment translates into AI results.
Psychological
Safety
Leadership
Transparency
Adoption
Momentum
Cultural
Resilience
diagnostic report
The report names your tier, identifies the specific category leaking the most adoption, and quantifies the cost of staying where you are.
This is not a generic results page. It’s a strategic diagnostic written for senior leaders, designed to be read in seven minutes and acted on the same week.
Delivered to your inbox
in minutes.
Developed for senior
leaders and teams
that are ready to scale.

About
Dr. Michelle Rozen
Behavioral scientist. Bestselling author. The Change Doctor™.
Dr. Michelle Rozen is a behavioral scientist and bestselling author of The Change Doctor’s Playbook for Adapting to AI. Her national study of more than 5,000 professionals on the psychological barriers to AI adoption became the foundation of her proprietary AI Readiness Behavioral Model™ - now deployed by Fortune 500 organizations including Pfizer, Coca-Cola, FedEx, Marriott, and Johnson & Johnson.
